The Effect of Virtual Exercises on Glycemic Control, Body Composition, Psychological Status and Quality of Life in Type 2 Diabetic Patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 68
- Locations
- 1
- Primary Endpoint
- Glycemic Control Analysis
Study Overview
Brief Summary
This study was conducted to evaluate the effect of exercises with VR goggles in patients with type 2 diabetes.
The effect of exercise in virtual reality goggles on glycemic control, body composition, quality of life and psychological status.
Detailed Description
For virtual reality applications, a screen will be worn on the user's head that provides a three-dimensional visual image, thus creating a sense of space and depth. Blood glucose levels, vital signs and oxygen consumption capacity measurements will be monitored with the smart watch throughout the VR exercise application.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- Single (Participant)
Masking Description
Virtual reality glasses and control group
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Being over 18 years old able to communicate Volunteering to participate in the research
Exclusion Criteria
- •Those with psychiatric problems Being unconscious
Arms & Interventions
Virtual reality glasses
Patients with type 2 diabetes were planned to exercise for 10 minutes warm-up and 10 minutes cool down and 30 minutes exercise for 50 minutes in total
Intervention: exercise with virtual reality goggles (Other)
Control group
Routine maintenance will be applied
Outcomes
Primary Outcomes
Glycemic Control Analysis
Time Frame: 3 months
HbA1c levels of patients in the intervention and control groups will be checked
Analysis of Body Composition Values
Time Frame: 3 months
Body analysis will be performed with a validated device. The patient will be measured before and after exercise and fat mass, lean mass, muscle mass, visceral fat ratio and basal metabolic rate will be measured by the device.
fat mass
Time Frame: 3 months
patients will be tested for fat mass on the device
lean mass
Time Frame: 3 months
patients will have a device to check their lean mass.
muscle mass
Time Frame: 3 months
patients' muscle mass will be checked with the device
visceral fat content
Time Frame: 3 months
patients will be tested for visceral fat with the device
basal metabolic rate
Time Frame: 3 months
patients' basal metabolic rate will be monitored with the device
Secondary Outcomes
- Depression Anxiety Stress Scale(3 months)
- SF-36 Quality of Life Scale(3 months)
- Satisfaction Survey(3 months)
Investigators
Kibar BZK
Investigator
Istanbul Sabahattin Zaim University